NCT04580888

Brief Summary

Acute circulatory failure that combines hypovolemia, vasoplegia and cardiac dysfunction plays a major role in the development of sepsis-related organ dysfunction. Pathophysiological mechanisms are multiple and complex. The objective of the GENESIS study is to determine the impact of early haemodynamic assessment using echocardiography in association with a therapeutic algorithm (intervention arm), when compared with standard of care based on the current Surviving Sepsis Campaign (SSC) recommendations (control arm), on the development of organ dysfunctions in patients admitted to the Emergency Department for sepsis or septic shock.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
312

participants targeted

Target at P50-P75 for not_applicable sepsis

Timeline
Completed

Started Jul 2021

Longer than P75 for not_applicable sepsis

Geographic Reach
1 country

10 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 9, 2020

Completed
10 months until next milestone

Study Start

First participant enrolled

July 23, 2021

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 8, 2025

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2025

Completed
Last Updated

November 21, 2025

Status Verified

November 1, 2025

Enrollment Period

3.7 years

First QC Date

September 28, 2020

Last Update Submit

November 18, 2025

Conditions

Keywords

SepsisEchocardiographyHaemodynamicEmergency Medicine

Outcome Measures

Primary Outcomes (1)

  • Change in Sequential Organ Failure Assessment (SOFA) score

    Crude variation of the SOFA score between inclusion and 24h following randomization.

    change from Hour 0 at Day 1

Secondary Outcomes (20)

  • Interruption of fluid resuscitation

    Hour 3

  • Maintains of fluid resuscitation

    Hour 3

  • Initiation of inotropes

    Hour 3

  • Initiation of vasopressor support

    Hour 3

  • Therapeutic modification

    Hour 3

  • +15 more secondary outcomes

Study Arms (2)

Intervention arm

EXPERIMENTAL

Assessment using an early transthoracic echocardiography (after 500 mL of fluids) to identify the hemodynamic profile responsible for the acute circulatory failure associated with sepsis / septic shock and to guide ongoing treatment (therapeutic algorithm) and monitor its efficacy and tolerance.

Procedure: early transthoracic echocardiography

Control arm

OTHER

Conventional management according to current standards of care based on SSC recommendations, including a standardized fluid resuscitation of 30 mL/kg.

Procedure: standards of care

Interventions

In the intervention arm, echocardiography will be performed immediately and potentially repeated to confirm the need for additional fluid resuscitation up to 30 mL/kg in the presence of persisting hypovolemia, or not (e.g., severe ventricular dysfunction). A therapeutic algorithm will allow standardized impact on ongoing management according to the hemodynamic profile identified by early echocardiography. After the completion of initial fluid resuscitation up to 30 mL/kg if required, a new echocardiographic assessment will be systematically performed by the same operator to stop or not fluid resuscitation, and to potentially initiate another treatment according to both the hemodynamic profile and clinical context.

Intervention arm

In the control arm, patients will be treated according to standards of care based on current SSC recommendations, including a fluid resuscitation of 30 mL/kg.

Control arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients admitted to the ED
  • Age ≥ 18 years and affiliation to Social Security
  • With sepsis (Sepsis-3 definition):
  • Clinically suspected or documented acute infection
  • AND a quick score Sequential Organ Failure Assessment (qSOFA) ≥ 2 points with:
  • Systolic blood pressure ≤ 100 mmHg (1 point) requiring fluid loading
  • AND encephalopathy (1 point) OR respiratory rate ≥ 22 cpm (1 point) AND a systolic blood pressure ≤ 100 mmHg after 500 mL of crystalloid vascular filling - Informed consent

You may not qualify if:

  • Decision to limit care or moribund status
  • Pregnancy or breast feeding
  • Subject under juridical protection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

CH d'Albi

Albi, 81000, France

Location

CH d'Eaubonne - Montmorency

Eaubonne, 95600, France

Location

Grenoble university hospital

La Tronche, 38700, France

Location

Limgoes university hospital

Limoges, 87042, France

Location

Hospices civils de Lyon

Lyon, 69003, France

Location

Nantes university hospital

Nantes, 44093, France

Location

Nice university hospital

Nice, 06600, France

Location

Poitiers university hospital

Poitiers, 86000, France

Location

La réunion university hospital

Saint-Pierre, 97410, France

Location

Toulouse university hospital

Toulouse, 31059, France

Location

Related Publications (1)

  • Lafon T, Le Gouge A, Brit S, Giraudeau B, Vignon P. Impact of early haemodynamic assessment by echocardiography on organ dysfunction and outcome of patients admitted to the emergency department with sepsis or septic shock: protocol of a multicentre randomised controlled trial (GENESIS). BMJ Open. 2025 May 6;15(5):e098304. doi: 10.1136/bmjopen-2024-098304.

MeSH Terms

Conditions

SepsisToxemiaEmergencies

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsDisease Attributes

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 28, 2020

First Posted

October 9, 2020

Study Start

July 23, 2021

Primary Completion

April 8, 2025

Study Completion

April 15, 2025

Last Updated

November 21, 2025

Record last verified: 2025-11

Locations